CVPATH INSTITUTE INC (EIN 204903376) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

ALOKE FINN MD

Phone

3012083570

Tax Period

2024-01-01 to 2024-12-31

CVPATH INSTITUTE INC, founded in 2004, is a mid-sized nonprofit in the Medical Research sector that reported $13.1M in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum.

Mission

TO CONDUCT TRANSLATIONAL "BENCH TO BEDSIDE" RESEARCH. TO PROVIDE CONSULTATION, HISTOLOGY, AND DIAGNOSTIC SERVICES TO PROMOTE DISCOVERIES TOWARDS ADVANCING TREATMENTS FOR CARDIOVASCULAR DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $387,111

Program Service Revenue $12,224,869

Investment Income $480,291

Other Revenue $0

TOTAL REVENUE $13,092,271

Expense Breakdown

Grants Paid $0

Salaries & Benefits $6,638,481

Fundraising Expenses $0

Program Expenses $12,847,370

Other Expenses $7,342,300

TOTAL EXPENSES $13,980,781

Year-over-Year Comparison

	2024	2023	Change
Revenue	$13,092,271	$10,519,461	+0.2%
Expenses	$13,980,781	$10,224,063	+0.4%
Net Income	$-888,510	$295,398	-4.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$1,119,524

Total Directors

$1,119,524

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALOKE FINN MD	PRESIDENT & CHIEF SCIENTIFIC OFFICER	40.00	Officer Director	$575,559	$50,796	$626,355
RENU VIRMANI FINN	FOUNDER & PRESIDENT EMERITUS	40.00	Officer Director	$469,019	$24,150	$493,169
CHESTER E FINN JR EDD	SECRETARY	1.00	Officer Director	$0	$0	$0
STEVEN C KRAUSE	TREASURER	1.00	Officer Director	$0	$0	$0
AZIN PARHIZGAR MSC PHD	CHAIR OF THE BOARD	1.00	Director	$0	$0	$0
ANDREW BRAUMANN	DIRECTOR	1.00	Director	$0	$0	$0
MOSHE Y FLUGELMAN MD	VICE CHAIR OF THE BOARD	1.00	Director	$0	$0	$0
CHARLES HONG MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
CRAIG KENNEDY	DIRECTOR	1.00	Director	$0	$0	$0
WOODY N PETERSON JD	DIRECTOR	1.00	Director	$0	$0	$0
MARIA ROMERO MD	CHIEF OF ANATOMIC PATHOLOGY	40.00	Highest	$262,294	$17,068	$279,362
ELENA RUTH LADICH	SENIOR PATHOLOGIST	40.00	Highest	$236,790	$29,739	$266,529
FRANK KOLODGIE PHD	ASSOCIATE DIRECTOR	40.00	Highest	$215,569	$14,017	$229,586
TINA RICHARDS	DIRECTOR, BUSINESS OPERATIONS & ADMINISTRATION	40.00	Highest	$137,221	$26,962	$164,183
ROBERT KUTYS MD	SENIOR PATHOLOGIST ASSISTANT	40.00	Highest	$124,430	$37,427	$161,857

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$13,092,271	$13,980,781	$23,450,739	$-888,510
2023	$10,519,461	$10,224,063	$22,505,172	$295,398
2022	$10,254,119	$9,869,423	$20,790,736	$384,696
2021	$13,233,897	$10,604,871	$16,751,910	$2,629,026
2020	$10,525,646	$11,952,933	$15,820,010	$-1,427,287

CVPATH INSTITUTE INC